{"id":"NCT01510912","sponsor":"Iroko Pharmaceuticals, LLC","briefTitle":"Open-Label Study of Diclofenac Capsules to Treat Osteoarthritis Pain","officialTitle":"A Multicenter, Open-Label, Safety Study of Diclofenac [Test] Capsules in Subjects With Osteoarthritis of the Knee or Hip","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01","primaryCompletion":"2013-03","completion":"2013-03","firstPosted":"2012-01-18","resultsPosted":"2014-05-09","lastUpdate":"2014-05-09"},"enrollment":602,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Osteoarthritis"],"interventions":[{"type":"DRUG","name":"Diclofenac","otherNames":[]}],"arms":[{"label":"Diclofenac Capsules 35 mg bid or tid","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the safety of Diclofenac \\[Test\\] Capsules for the treatment of osteoarthritis pain of the knee or hip.","primaryOutcome":{"measure":"Safety of Diclofenac 35 mg Capsules as Assessed by the Incidence of Adverse Events From Baseline to Week 52 or Early Termination","timeFrame":"Baseline to Week 52/Early Termination","effectByArm":[{"arm":"Diclofenac 35 mg Capsules","deltaMin":451,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":40,"countries":["United States"]},"refs":{"pmids":["25913498"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":42,"n":601},"commonTop":["Upper respiratory tract infection","Headache","Urinary tract infection","Diarrhea","Nasopharyngitis"]}}